rs746882521
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_176787.5(PIGN):c.932T>G(p.Leu311Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000128 in 1,518,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (โ โ ). Synonymous variant affecting the same amino acid position (i.e. L311L) has been classified as Likely benign.
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PIGN | NM_176787.5 | c.932T>G | p.Leu311Trp | missense_variant | 11/31 | ENST00000640252.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PIGN | ENST00000640252.2 | c.932T>G | p.Leu311Trp | missense_variant | 11/31 | 1 | NM_176787.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000460 AC: 7AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000298 AC: 6AN: 201228Hom.: 0 AF XY: 0.0000373 AC XY: 4AN XY: 107164
GnomAD4 exome AF: 0.000137 AC: 187AN: 1366282Hom.: 0 Cov.: 22 AF XY: 0.000143 AC XY: 97AN XY: 679794
GnomAD4 genome ? AF: 0.0000460 AC: 7AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 08, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 26, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 311 of the PIGN protein (p.Leu311Trp). This variant is present in population databases (rs746882521, gnomAD 0.006%). This missense change has been observed in individual(s) with multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS) (PMID: 28327575). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 426983). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIGN protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PIGN function (PMID: 28327575). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Undiagnosed Diseases Network, NIH | May 24, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 21, 2023 | Variant summary: PIGN c.932T>G (p.Leu311Trp) results in a non-conservative amino acid change located in the GPI ethanolamine phosphate transferase 1, N-terminal domain (IPR037671) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3e-05 in 201228 control chromosomes. c.932T>G has been reported in the literature as a biallelic genotype in multiple individuals affected with features of Multiple Congenital Anomalies-Hypotonia Syndrome 1 (PIGN-encephalopathy) (example, Jezela-Stanek_2016, Pagnamenta_2017, Angione_2019, Powis_2020, Pronicka_2016, Bayat_2022). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 30660939, 35179230, 26879448, 28327575, 31628766, 27290639, 31440721). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n=7)/likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Jan 26, 2024 | PS3, PM3_Strong, PM2, - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU Mรผnchen | Jun 05, 2019 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | PIGN: PM3:Very Strong, PM2, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 26, 2022 | Published functional studies demonstrate that this variant results in significantly reduced enzymatic activity (Pagnamenta et al., 2017); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26879448, 27290639, 27038415, 28327575, 30660939, 32585529, 31589614, 33619735, 35179230) - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2018 | The p.L311W variant (also known as c.932T>G), located in coding exon 8 of the PIGN gene, results from a T to G substitution at nucleotide position 932. The leucine at codon 311 is replaced by tryptophan, an amino acid with similar properties. This alteration was identified in an individual who had seizures, developmental delay, brain atrophy, and dysmorphic features and was compound heterozygous with another alteration p.G264R (Jezela-Stanek A et al. Eur. J. Paediatr. Neurol., 2016 May;20:462-73). This alteration was also identified in a different individual with cognitive impairment, seizures, extrapyramidal dyskinesia, dysmorphic features, and brain atrophy in the compound heterozygous state with the p.K232*. In addition, functional studies suggest decreased enzymatic activity and reduced expression of GPI-APs in patient granulocytes (Pagnamenta AT et al. Eur. J. Hum. Genet., 2017 06;25:669-679; Jezela-Stanek A et al. Eur. J. Paediatr. Neurol., 2016 May;20:462-73). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at